NICE advises against prescribing zanamivir until further evidence emerges.
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011714:Pyrans; D012307:Risk Factors; D012794:Sialic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D053243:Zanamivir
D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir